Results 111 to 120 of about 4,216,927 (283)
RISK OF OBESITY FOR HYPERTENSION DIFFERS BETWEEN DIABETIC AND NON-DIABETIC SUBJECTS
In recent years, non-communicable diseases (NCD) like obesity, hypertension (HTN) and Type2 diabetes (T2DM) are on the increase, specially in the developing nations.
MA Sayeed +4 more
doaj
Overall cumulative odds ratio plot of temperature effect.
Overall cumulative odds ratio plot of temperature effect.
Yining Huang (240879) +13 more
core +1 more source
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley +1 more source
Justificación y objetivo:La infección intrahospitalaria por varicela en adultos es infrecuente, a pesar de ser una enfermedad altamente contagiosa.
Sócrates Vargas-Naranjo +1 more
doaj
Comparative assessment of mortality in different strains of broilers at the starter phase
Mortality in broilers has been a major setback and source of economic losses associated with broiler production. A total of 600 day-old chicks consisting of 200 each from three strains (Arbor Acre, Cobb 500 and Ross 308) were procured from a reputable ...
Olatunji Tajudeen Fazazi Abanikannda +5 more
doaj +1 more source
ODDS RATIO: A RESULT OF BUSINESS RESEARCH ANALYSIS [PDF]
The results of applied research in the field of good business deserve to be used as a material in the decision making process at the top level managers of a company (industry).
Karnowahadi, Karnowahadi -
core
Forest plot of odds ratio on BCS rate
Forest plot of odds ratio on BCS ...
Xiao-lei Hu (840722) +5 more
core +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
New insights and potential clinical implications of the odds ratio product. [PDF]
Younes M.
europepmc +1 more source
Odds ratio of complication given DM, age ≥65.
Odds ratio of complication given DM, age ≥65.
Lynn M. Frydrych (7321589) +5 more
core +1 more source

